15 March 2012 16:56 [Source: ICIS news]
LONDON (ICIS)--JP Morgan Cazenove has downgraded ?xml:namespace>
JP Morgan Cazenove said it was concerned how well some of Bayer’s pharmaceutical products will perform in 2012, as launches in the
However, the bank said it remains confident that Bayer will see these products improve in the long term.
It added that Bayer will also gain momentum from expansions in its crop science and material science businesses.
JP Morgan Cazenove raised Bayer’s share target price to €62 ($81) from €58.
At 16.03 GMT, Bayer’s shares on the London Stock Exchange were trading at €54.53, down by 1.32% from the previous close.
($1 = €0.77)
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections